| Add to balance / Manage account | User: | Log out |
| Prospect News home > News index > List of issuers S > Headlines for Surgery Partners, Inc. > News item |
S&P lifts Surgery Partners
S&P said it raised its ratings on Surgery Partners Inc. and its senior secured first-lien debt to B from B- as well as the senior secured second-lien debt to CCC+ from CCC. The 3 and 6 recovery ratings, respectively, are unchanged.
“We expect Surgery Partners to grow its revenue over 8% in 2023 and maintain its EBITDA margin at about 15% through 2025. The company continues to benefit from a favorable mix of higher-acuity musculoskeletal surgical procedures and pain management that result in a higher EBITDA margin than peers. Additionally, with moderating wage inflation, we are increasingly confident the company's EBITDA margin will remain at current levels or expand as it grows, which will drive incremental cash flow generation,” S&P said in a press release.
The outlook is stable.
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.